Micah Zajic - 11 Jul 2022 Form 4 Insider Report for SQZ Biotechnologies Co

Role
Chief Financial Officer
Signature
/s/ Lawrence Knopf, Attorney-in-Fact for Micah Zajic
Issuer symbol
N/A
Transactions as of
11 Jul 2022
Net transactions value
$0
Form type
4
Filing time
13 Jul 2022, 17:00:17 UTC
Previous filing
15 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SQZB Stock Option Award $0 +10,000 $0.000000 10,000 11 Jul 2022 Common Stock 10,000 $3.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% of the underlying securities on July 11, 2023 and in 36 substantially equal monthly installments thereafter.